Thirty-fifth Meeting of the Caribbean Immunization Managers. Final Report
Fecha
2022Número de documento
PAHO/FPL/IM/22-0002
Metadatos
Mostrar el registro completo del ítemResumen
The 35th Caribbean EPI Managers’ Meeting was held virtually from 3-5 November 2021. The meeting convened 71 participants from 28 countries and territories of the English, Dutch and French-speaking Caribbean. Participants included representatives from the Ministries of Health, the Caribbean Public Health Agency (CARPHA), the Caribbean Community (CARICOM) and the Pan American Health Organization/World Health Organization (PAHO/WHO). The overall objective is to analyze achievements for 2020, review the challenges of 2020 and 2021 in the context of the COVID-19 pandemic, and plan activities for 2022 while sharing country experiences on the immunization program.
Tema
Colecciones
Esta leyenda debe conservarse, junto con la URL original del artículo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Pan American Health Organization; Office of the Subregional Program Coordination, Caribbean (CPC) (PAHOUnited StatesWashington, D.C., 2021)The Caribbean has a long history of being a global leader in immunization, and one of the key factors contributing to this success has been the commitment and dedication of healthcare workers in promoting the benefits of ...
-
Etienne, Carissa F. (2017)Childhood immunization programs have had a dramatic impact on child morbidity and mortality worldwide. In Latin America and the Caribbean, nearly 174 000 deaths were prevented through vaccination of children under 5 years ...
-
Maternal and Neonatal Immunization Field Guide for Latin America and the Caribbean – Annex COVID-19 Pan American Health Organization; Health Systems and Services (HSS) (PAHOUnited StatesWashington, D.C., 2023)This document is an annex to the Pan American Health Organization (PAHO) Maternal Neonatal Immunization Field Guide. This annex incorporates relevant information on COVID-19 vaccines to be considered by decision-makers who ...